Anti-LDOC1 antibodies are used in the immunodetection of the protein LDOC1 regulator of NFKB signaling. In humans, the canonical protein has a reported length of 146 amino acid residues and a mass of 17 kDa. Its subcellular localization is in the nucleus. It is widely expressed across many tissue types. A member of the LDOC1 protein family, LDOC1 is believed to have an important role in the development and/or progression of some cancers. Synonyms for this target antigen include Mart7, RTL7, SIRH7, protein LDOC1, Sushi-Ichi retrotransposon homolog 7, and BCUR1. LDOC1 gene orthologs have been reported in the mouse, rat and chimpanzee species. A number of LDOC1 antibodies have been mentioned in research publications and have associated citations. Immunohistochemistry is a widely used application for these antibodies. In addition, Western Blot is also a common application.